Cenderitide
- Generic Name
- Cenderitide
- Drug Type
- Biotech
- CAS Number
- 507289-11-4
- Unique Ingredient Identifier
- 9NKZ9LYZ06
- Background
Cenderitide is under investigation for the treatment of ST Elevation (STEMI) Myocardial Infarction of Anterior Wall.
Safety Study of CD-NP in Heart Failure
Phase 1
Completed
- Conditions
- Congestive Heart Failure
- First Posted Date
- 2007-11-14
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- Nile Therapeutics
- Target Recruit Count
- 20
- Registration Number
- NCT00557661
Safety and Pharmacodynamic Study of CD-NP
Phase 1
Completed
- Conditions
- Heart Failure, Congestive
- First Posted Date
- 2007-06-06
- Last Posted Date
- 2007-06-06
- Lead Sponsor
- Nile Therapeutics
- Target Recruit Count
- 22
- Registration Number
- NCT00482937
- Locations
- 🇺🇸
DaVita Clinical Research, Minneapolis, Minnesota, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath